SAN ANTONIO--(BUSINESS WIRE)--Santalis Pharmaceuticals announced today the successful spin-off of Roxy’s Remedies, Inc., a new brand of natural luxury grooming products for dogs with sensitive skin. Series A financing for Roxy’s was secured from the San Antonio-based Targeted Technology Fund to commercialize Roxy’s proprietary veterinary skin care line.
